Kindred Healthcare, Inc. (KND) Sees Significant Decline in Short Interest

Kindred Healthcare, Inc. (NYSE:KND) was the recipient of a significant decrease in short interest in December. As of December 29th, there was short interest totalling 3,097,042 shares, a decrease of 47.1% from the December 15th total of 5,849,880 shares. Currently, 3.5% of the shares of the stock are sold short. Based on an average daily volume of 4,576,974 shares, the short-interest ratio is presently 0.7 days.

Shares of Kindred Healthcare (NYSE KND) opened at $9.15 on Friday. The company has a debt-to-equity ratio of 6.22, a quick ratio of 1.53 and a current ratio of 1.55. The firm has a market cap of $859.79, a PE ratio of -1.52 and a beta of 1.20. Kindred Healthcare has a 52 week low of $5.50 and a 52 week high of $11.90.

Kindred Healthcare (NYSE:KND) last issued its quarterly earnings data on Monday, November 6th. The health services provider reported ($0.11) earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.19) by $0.08. The firm had revenue of $1.48 billion for the quarter, compared to analysts’ expectations of $1.44 billion. Kindred Healthcare had a negative net margin of 8.06% and a positive return on equity of 2.29%. The company’s quarterly revenue was down 5.5% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.05 earnings per share. sell-side analysts predict that Kindred Healthcare will post 0.31 EPS for the current fiscal year.

A number of institutional investors have recently modified their holdings of the business. BlackRock Inc. grew its stake in Kindred Healthcare by 0.3% during the second quarter. BlackRock Inc. now owns 10,808,864 shares of the health services provider’s stock worth $125,923,000 after buying an additional 29,673 shares during the last quarter. Vanguard Group Inc. grew its stake in Kindred Healthcare by 8.6% during the second quarter. Vanguard Group Inc. now owns 8,031,919 shares of the health services provider’s stock worth $93,572,000 after buying an additional 635,000 shares during the last quarter. Dimensional Fund Advisors LP grew its stake in Kindred Healthcare by 5.6% during the second quarter. Dimensional Fund Advisors LP now owns 6,004,440 shares of the health services provider’s stock worth $69,952,000 after buying an additional 315,752 shares during the last quarter. JPMorgan Chase & Co. grew its stake in Kindred Healthcare by 69.8% during the third quarter. JPMorgan Chase & Co. now owns 3,572,684 shares of the health services provider’s stock worth $24,830,000 after buying an additional 1,468,066 shares during the last quarter. Finally, Glenview Capital Management LLC grew its stake in Kindred Healthcare by 18.8% during the second quarter. Glenview Capital Management LLC now owns 2,374,713 shares of the health services provider’s stock worth $27,665,000 after buying an additional 375,000 shares during the last quarter. 85.16% of the stock is currently owned by hedge funds and other institutional investors.

Several research analysts recently issued reports on KND shares. Zacks Investment Research raised shares of Kindred Healthcare from a “sell” rating to a “hold” rating in a research report on Tuesday, November 21st. Royal Bank of Canada reissued a “sector perform” rating and issued a $8.50 price target (up previously from $7.50) on shares of Kindred Healthcare in a research report on Thursday, November 9th. ValuEngine raised shares of Kindred Healthcare from a “sell” rating to a “hold” rating in a research report on Thursday, November 9th. Stifel Nicolaus raised shares of Kindred Healthcare from a “sell” rating to a “hold” rating and set a $7.00 price target for the company in a research report on Monday, November 20th. Finally, Mizuho set a $9.00 price target on shares of Kindred Healthcare and gave the stock a “hold” rating in a research report on Monday, December 18th. Two analysts have rated the stock with a sell rating, seven have given a hold rating and one has assigned a buy rating to the company. Kindred Healthcare currently has an average rating of “Hold” and an average target price of $9.31.

TRADEMARK VIOLATION WARNING: This report was posted by The Ledger Gazette and is the property of of The Ledger Gazette. If you are reading this report on another site, it was copied illegally and republished in violation of United States & international copyright and trademark law. The original version of this report can be viewed at https://ledgergazette.com/2018/01/21/kindred-healthcare-inc-knd-sees-significant-decline-in-short-interest.html.

About Kindred Healthcare

Kindred Healthcare, Inc, incorporated on March 27, 1998, is a healthcare services company. The Company, through its subsidiaries, operates transitional care (TC) hospitals, a home health, hospice and community care business, inpatient rehabilitation hospitals (IRFs), a contract rehabilitation services business, nursing centers and assisted living facilities across the United States.

Receive News & Ratings for Kindred Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kindred Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply